Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C, study finds

The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer.